
NASDAQHealthcareMedical - Distribution
Latest quote
$84.01
−$0.62 · -0.73%
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Previous close
$84.01
−$0.62 · -0.73%
Regular session · ET · Market data may be delayed.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Day range
Current $84.01
52-week range
Current $84.01
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
71
Undervalued
Sentiment
63
Bullish
Risk
20
Low Risk
Momentum
53
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Day range
Current $84.01
52-week range
Current $84.01
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.18B USD | 12.67B USD | 12.34B USD | 12.65B USD | 12.4B USD |
| Cost of goods sold | 9.34B USD | 8.91B USD | 8.69B USD | 9B USD | 8.73B USD |
| Gross profit | 3.84B USD | 3.77B USD | 3.65B USD | 3.65B USD | 3.67B USD |
| Selling, general, and administrative | 3.08B USD | 3.04B USD | 2.94B USD | 2.71B USD | 2.82B USD |
| Operating expenses | 3.08B USD | 3.04B USD | 2.94B USD | 2.71B USD | 2.82B USD |
| Interest income | 33M USD | 24M USD | 17M USD | 17M USD | 6.45M USD |
| Interest expense | 150M USD | 131M USD | 87M USD | 44M USD | 27.6M USD |
| Depreciation and amortization | 311M USD | 268M USD | 222M USD | 212M USD | 209.53M USD |
| Operating income | 758M USD | 729M USD | 714M USD | 938M USD | 854.81M USD |
| Net income | 398M USD | 390M USD | 416M USD | 538M USD | 623.91M USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$92.33
9.90% upsideFunds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR S&P 500 ETF1557.T15.87B0.01%129.34T JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI277.9M0.01%2.3T USD0.03%$381.94+0.63%
Vanguard S&P 500 ETFVOO230.88M0.01%1.8T USD0.03%$715.59+0.61%
Vanguard Morningstar Small-Cap ETFVB200.86M0.11%185.3B USD0.03%$289.48+0.64%
Invesco S&P 500 Equal Weight ETFRSP187.49M0.19%96.75B USD0.20%$213.04+0.55%
Vanguard Morningstar Small-Cap Value ETFVBR127.62M0.19%68.2B USD0.05%$234.43+0.22%
iShares Core S&P 500 ETFIVV107.86M0.01%892.79B USD0.03%$781.97+0.60%
State Street SPDR S&P 500 ETFSPY100.26M0.01%817.2B USD0.09%$778.57+0.60%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Small-Cap ETFVB
Invesco S&P 500 Equal Weight ETFRSP
Vanguard Morningstar Small-Cap Value ETFVBR
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPYAI-generated and delayed market data for informational and educational purposes only. Not investment advice.